In the aftermath of the COVID-19 pandemic, Gavi faces an unprecedented situation. Billions of dollars that it raised back in 2022 for COVAX—the global effort to provide COVID-19 vaccines to lower-income countries—remain unspent. These resources are substantial, exceeding the entire annual budget of ...

When Gavi’s board meets in Accra, Ghana, next week, advancing discussions on a new five-year strategic period, known as “Gavi 6.0,” will be a top agenda item. But conversations about Gavi’s future direction are also taking place against the backdrop of a leadership transition and a rapidly changing ...

Since 2019, the UK’s strong reputation in global health has been undermined by a series of cuts and a distracting departmental reorganisation. November 2023 may represent a turning point—with a new Foreign Minister who has historically championed aid as Prime Minister, and the publication of a new i...

Regulation plays a vital role in ensuring the quality, safety, and efficacy of vaccines—and a strong regulatory system is key to successfully expanding vaccine manufacturing. The Gavi Secretariat is currently fine-tuning the design of a new Advance Market Commitment (AMC)—a financial mechanism to su...

The COVID-19 pandemic spurred an acceleration in the development of global health technologies. These technologies—many of which are only just coming to market—have the potential to reshape health systems, with significant positive impacts on global health security and pandemic preparedness.

One of the most salient lessons from the pandemic is the need to diversify manufacturing capabilities and bolster supply resilience to avoid a repeat of the slow and inequitable vaccine roll out in African countries. To turn this lesson into action, the Gavi Secretariat is rapidly advancing plans fo...

Low-income and many emerging market economies face a challenging outlook for maintaining, let alone increasing, health and other social expenditures (as noted in these recent blogs here and here). This predicament is primarily attributed to these nations channeling a growing proportion of their reve...

During the COVID-19 pandemic, whole genomic sequencing (WGS)-based surveillance played a key role in identifying variants of concern, investigating their spread and transmissibility, and facilitating the design and optimization of medical countermeasures, including diagnostic tools and vaccines. How...

The COVID-19 pandemic caused losses of lives and livelihoods on a scale that many of us had never seen in our lifetimes, shedding light on the ways that pandemics are a “neglected dimension” of global security. And yet, as we are already observing, proposals for increased, sustained support for surv...